Case Study: ImClone Systems achieves 53% faster turnaround and 25% higher testing capacity with STARLIMS SDMS

How Starlims Sdms Helped Imclone Cut Costs and Boost Productivity

ImClone Systems, a wholly owned subsidiary of Eli Lilly focused on oncology drug development and manufacturing, was hindered by a fully paper‑based laboratory testing process that could not scale: a forecasted 64% increase in submissions risked a ~40% headcount increase, slower turnaround, high paper costs and higher error rates. To modernize testing and data management, ImClone Systems selected STARLIMS and its STARLIMS Scientific Data Management System (SDMS) together with STARLIMS LIMS to automate sample receipt, tracking and instrument data capture.

STARLIMS implemented a web‑based LIMS tightly integrated with STARLIMS SDMS to attach instrument files electronically, enable paperless assays and allow remote reviewer approvals. The deployment cut average API test turnaround from 60 to 28 days (a 53% reduction), increased testing volume by 25% without added headcount, eliminated a projected 65% rise in paper printing/management/storage costs, reduced errors and noticeably boosted laboratory productivity.

ImClone Systems

Richard Caron

Associate Director